{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:00:11Z","timestamp":1780992011067,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clml.2025.10.023","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:03:04Z","timestamp":1762012984000},"page":"e344-e356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Double-Faced t(12;21) in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Patients: Seven Years Experience at a Tertiary Center"],"prefix":"10.1016","volume":"26","author":[{"given":"Eman O.","family":"Rasekh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-4406","authenticated-orcid":false,"given":"Mustafa","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-1802","authenticated-orcid":false,"given":"Hend","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona S. El","family":"Ashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2025.10.023_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2019.109023","article-title":"Early immune stimulation and childhood acute lymphoblastic leukemia in Costa Rica: a comparison of statistical approaches","volume":"182","author":"Figueroa","year":"2020","journal-title":"Environ Res"},{"issue":"3","key":"10.1016\/j.clml.2025.10.023_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"issue":"29","key":"10.1016\/j.clml.2025.10.023_bib0003","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.2018.77.7250","article-title":"Improved survival for children and young adults with T-lineage acute lymphoblastic leukemia: results from the Children\u2019s Oncology Group AALL0434 methotrexate randomization","volume":"36","author":"Winter","year":"2018","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.clml.2025.10.023_bib0004","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1182\/bloodadvances.2019000576","article-title":"Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity","volume":"3","author":"Schramm","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.clml.2025.10.023_bib0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.19.01086","article-title":"Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: results of Children\u2019s Oncology Group Trial AALL0331","volume":"38","author":"Maloney","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clml.2025.10.023_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12288-020-01295-8","article-title":"Recent advances in molecular diagnosis and prognosis of childhood B cell lineage acute lymphoblastic leukemia (B-ALL)","volume":"37","author":"Agarwal","year":"2021","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"7","key":"10.1016\/j.clml.2025.10.023_bib0007","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2025.10.023_bib0008","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2005-08-3451","article-title":"Prospective analysis of TEL\/AML1-positive patients treated on Dana-Farber Cancer Institute consortium protocol 95-01","volume":"107","author":"Loh","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2025.10.023_bib0009","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2008.06980.x","article-title":"Outcome of ETV6\/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival","volume":"140","author":"Forestier","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.clml.2025.10.023_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/leu.2011.227","article-title":"ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy","volume":"26","author":"Bhojwani","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.clml.2025.10.023_bib0011","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4143\/crt.2016.211","article-title":"Outcome and prognostic factors for ETV6\/RUNX1 positive pediatric acute lymphoblastic leukemia treated at a single institution in Korea","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res Treat"},{"issue":"21","key":"10.1016\/j.clml.2025.10.023_bib0012","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16367","article-title":"Pathogenesis of ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.clml.2025.10.023_bib0013","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","article-title":"A causal mechanism for childhood acute lymphoblastic leukaemia","volume":"18","author":"Greaves","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"10.1016\/j.clml.2025.10.023_bib0014","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1073\/pnas.0402063101","article-title":"Modeling first-hit functions of the t (12; 21) TEL-AML1 translocation in mice","volume":"101","author":"Tsuzuki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.clml.2025.10.023_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.stem.2009.04.019","article-title":"TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia","volume":"5","author":"Schindler","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"9881","key":"10.1016\/j.clml.2025.10.023_bib0016","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"The Lancet"},{"issue":"7137","key":"10.1016\/j.clml.2025.10.023_bib0017","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clml.2025.10.023_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.797194","article-title":"Prognostic value and outcome for ETV6\/RUNX1-positive pediatric acute lymphoblastic leukemia: a report from the South China children\u2019s leukemia group","volume":"11","author":"Qiu","year":"2021","journal-title":"Front Oncol"},{"issue":"1159","key":"10.1016\/j.clml.2025.10.023_bib0019","article-title":"An International System for human Cytogenomic Nomenclature","volume":"149","author":"McGowan-Jordan","year":"2016","journal-title":"Cytogenetic and Genome Research"},{"issue":"12","key":"10.1016\/j.clml.2025.10.023_bib0020","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease","volume":"13","author":"Van Dongen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.10.023_bib0021","first-page":"S124","article-title":"Rationale and design of total therapy study XV for newly diagnosed childhood acute lymphoblastic leukemia","volume":"83","author":"Pui","year":"2004","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.clml.2025.10.023_bib0022","first-page":"1","article-title":"Overview the causes of early deaths and advance supportive care in children with acute lymphoblastic leukemia: a systematic review","volume":"14","author":"Shakibazad","year":"2022","journal-title":"Iran J Blood"},{"issue":"21","key":"10.1016\/j.clml.2025.10.023_bib0023","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood.V124.21.2403.2403","article-title":"ETV6\/RUNX1-postitive childhood acute lymphoblastic leukemia (ALL): do additional aberrations influence treatment response and outcome?","volume":"124","author":"Ampatzidou","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2025.10.023_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.797194","article-title":"Prognostic value and outcome for ETV6\/RUNX1-positive pediatric acute lymphoblastic leukemia: a report from the south China children\u2019s leukemia group","volume":"11","author":"Qiu","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clml.2025.10.023_bib0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood.2024024936","article-title":"Outcomes in patients with ETV6:: RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV\/XVI studies","volume":"145","author":"Purvis","year":"2025","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2025.10.023_bib0026","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4143\/crt.2020.507","article-title":"Differing outcomes of patients with high hyperdiploidy and ETV6-RUNX1 rearrangement in Korean pediatric precursor B cell acute lymphoblastic leukemia","volume":"53","author":"Lee","year":"2021","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clml.2025.10.023_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","article-title":"Biology of childhood acute lymphoblastic leukemia","volume":"62","author":"Bhojwani","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"7-8","key":"10.1016\/j.clml.2025.10.023_bib0028","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cancergen.2016.06.004","article-title":"Chromosomal aberrations in childhood acute lymphoblastic leukemia: 15-year single center experience","volume":"209","author":"Jarosova","year":"2016","journal-title":"Cancer Genetics"},{"issue":"1","key":"10.1016\/j.clml.2025.10.023_bib0029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/leu.2017.289","article-title":"Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials","volume":"32","author":"Piette","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.10.023_bib0030","first-page":"1","article-title":"Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients\u2019 outcome","author":"Abdelfattah","year":"2024","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.clml.2025.10.023_bib0031","first-page":"681","article-title":"Prevalence of ETV6\/RUNX1 fusion gene in pediatric patients with acute lymphoblastic leukemia in Iran","volume":"23","author":"Rahnemoon","year":"2013","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.clml.2025.10.023_bib0032","first-page":"154","article-title":"Evaluation of ETV6\/RUNX1 fusion and additional abnormalities involving ETV6 and\/or RUNX1 genes using FISH technique in patients with childhood acute lymphoblastic leukemia","volume":"32","author":"Aydin","year":"2016","journal-title":"Indian J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2025.10.023_bib0033","first-page":"17","article-title":"Study of the childhood acute lymphoblastic leukemia with t (12; 21)","volume":"25","author":"Lin","year":"2004","journal-title":"Zhonghua xue ye xue za zhi= Zhonghua Xueyexue Zazhi"},{"key":"10.1016\/j.clml.2025.10.023_bib0034","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2020-142754","article-title":"Response adapted therapy in ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia treated per modified St Jude Total XV study","volume":"136","author":"Shanap","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2025.10.023_bib0035","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1365-2141.1999.01425.x","article-title":"An investigation of the t (12; 21) rearrangement in children with B-precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods","volume":"105","author":"Kempski","year":"1999","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.clml.2025.10.023_bib0036","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood.V108.11.2283.2283","article-title":"High hyperdiploidy and t (12; 21)(p13; q22) translocation is not a so rare association: a report of 4 cases in the experience of Armand Trousseau Hospital (Paris)","volume":"108","author":"Ballerini","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2025.10.023_bib0037","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3324\/haematol.2012.072470","article-title":"Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6\/RUNX1-positive acute lymphoblastic leukemia","volume":"99","author":"Bokemeyer","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.clml.2025.10.023_bib0038","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2141.2012.09083.x","article-title":"Genome-wide analysis of cytogenetic aberrations in ETV 6\/RUNX 1-positive childhood acute lymphoblastic leukaemia","volume":"157","author":"Borst","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2025.10.023_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-8166-5-41","article-title":"Chromosomal aberrations in ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia using 244K oligonucleotide array comparative genomic hybridization","volume":"5","author":"Zakaria","year":"2012","journal-title":"Mol Cytogenet"},{"issue":"21","key":"10.1016\/j.clml.2025.10.023_bib0040","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16367","article-title":"Pathogenesis of ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.clml.2025.10.023_bib0041","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08880010802237450","article-title":"RUNX1 aberrations in ETV6\/RUNX1-positive and ETV6\/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL","volume":"25","author":"Pais","year":"2008","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.clml.2025.10.023_bib0042","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.leu.2404083","article-title":"Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t (12; 21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome","volume":"20","author":"Stams","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.10.023_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2018.03.001","article-title":"ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): the spectrum of clonal heterogeneity and its impact on prognosis","volume":"224","author":"Ampatzidou","year":"2018","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1016\/j.clml.2025.10.023_bib0044","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/cells12030357","article-title":"The landscape of secondary genetic rearrangements in pediatric patients with B-cell acute lymphoblastic leukemia with t (12; 21)","volume":"12","author":"Kaczmarska","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.clml.2025.10.023_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ijlh.13369","article-title":"Duplication 1q is highly correlated with poor prognosis in high hyperdiploid pediatric B-acute lymphoblastic leukemia","volume":"43","author":"El Ashry","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.clml.2025.10.023_bib0046","article-title":"Fishing for ETV6\/RUNX1 fusion and MLL gene rearrangements and their additional abnormalities in childhood acute lymphoblastic leukemia patients of Kashmir","volume":"856","author":"Malla","year":"2023","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.clml.2025.10.023_bib0047","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1080\/10428194.2022.2064991","article-title":"Apparent coexistence of ETV6:: RUNX1 and KMT2A:: MLLT3 fusions due to a nonproductive KMT2A rearrangement in B-ALL","volume":"63","author":"Gagnon","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.clml.2025.10.023_bib0048","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.leu.2404507","article-title":"Deletion of 11q23 is a highly specific nonrandom secondary genetic abnormality of ETV6\/RUNX1-rearranged childhood acute lymphoblastic leukemia","volume":"21","author":"Attarbaschi","year":"2007","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.clml.2025.10.023_bib0049","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41375-024-02287-7","article-title":"ETV6:: RUNX1 acute lymphoblastic leukemia: how much therapy is needed for cure?","volume":"38","author":"\u00d8stergaard","year":"2024","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.clml.2025.10.023_bib0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3324\/haematol.2012.072470","article-title":"Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6\/RUNX1-positive acute lymphoblastic leukemia","volume":"99","author":"Bokemeyer","year":"2014","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.clml.2025.10.023_bib0051","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1200\/JCO.20.02370","article-title":"Favorable trisomies and ETV6-RUNX1 predict cure in low-risk B-cell acute lymphoblastic leukemia: results from Children's Oncology Group trial AALL0331","volume":"39","author":"Mattano","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.10.023_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13052-018-0541-6","article-title":"ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol","volume":"44","author":"Wang","year":"2018","journal-title":"Italian Journal of Pediatrics"},{"issue":"9","key":"10.1016\/j.clml.2025.10.023_bib0053","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2411680","article-title":"Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children","volume":"392","author":"Gupta","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025042624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025042624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:42:20Z","timestamp":1780990940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025042624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2152265025042624"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.10.023","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Double-Faced t(12;21) in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Patients: Seven Years Experience at a Tertiary Center","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}